Type 2 Diabetic Neuropathy in the GLP-1 Era
GLP-1 receptor agonists have substantially reshaped the therapeutic landscape for type 2 diabetes and obesity, and the indications now being pursued...
GLP-1 receptor agonists have substantially reshaped the therapeutic landscape for type 2 diabetes and obesity, and the indications now being pursued...
Drug development for chronic kidney disease has entered a more ambitious phase. SGLT2 inhibitors, non steroidal mineralocorticoid receptor...
The challenge in translational research is not generating data but generating actionable confidence.
Pain and wound healing research demand models that accurately reflect human tissue structure, innervation, and functional recovery. While rodents...
At this year’s Society for Neuroscience (SfN) meeting, our team presented a poster highlighting the advantages of using a porcine model to bridge the...
At the forefront of translational large-animal research, our team has developed clinically relevant pig models to study nerve injury and pain....
We had the opportunity to present at NeuPSIG 2025 in Berlin, sharing our latest findings in neuropathic pain research. The conference offered...
Spinal cord injury (SCI) remains one of the most challenging neurological conditions to treat, with few therapies successfully translating from the...
Bridging the gap between preclinical and clinical research remains one of the most pressing challenges in drug development. While early-stage studies...